West Pharmaceutical Services, Inc. (WST)

NYSE: WST · Real-Time Price · USD

Compare

231.12

-1.53 (-0.66%)

At close: Jan 30, 2026, 4:00 PM EST

230.99

-0.13 (-0.06%)

After-hours: Jan 30, 2026, 7:42 PM EST

WST Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	3,018	2,893	2,950	2,887	2,832	2,147
Revenue Growth (YoY)	4.92%	-1.92%	2.18%	1.95%	31.89%	16.69%
Cost of Revenue	1,944	1,895	1,820	1,751	1,654	1,379
Gross Profit	1,074	998.5	1,130	1,136	1,178	767.8
Selling, General & Admin	365.5	334.9	354.1	316	356.3	300.8
Research & Development	71	69.1	68.4	58.5	52.8	46.9
Other Operating Expenses	0.9	0.9	1.3	-2.1	-	-2.5
Operating Expenses	437.4	404.9	423.8	372.4	409.1	345.2
Operating Income	636.3	593.6	706.2	763.8	768.6	422.6
Interest Expense	-	-3	-9	-7.9	-8.2	-8.2
Interest & Investment Income	17.3	19.6	28	5.1	1	1.4
Earnings From Equity Investments	12.5	14.7	17.7	20.7	20.1	17.4
Currency Exchange Gain (Loss)	-8.5	-10.2	-9.4	4.1	1.4	1.5
EBT Excluding Unusual Items	657.7	614.7	733.5	785.8	782.9	434.7
Merger & Restructuring Charges	-24.9	-2.1	2	-23.8	-2.2	-4.6
Gain (Loss) on Sale of Investments	-0.3	-0.3	-4.3	-3.5	-4.3	-2.5
Gain (Loss) on Sale of Assets	-	-	-11.6	-	-	-
Asset Writedown	-6.5	-7	-5.3	-2.7	-4.1	-7.7
Legal Settlements	-	-	3.8	-	-	-
Other Unusual Items	-9.2	-5.1	-2.4	-55.2	-3.3	-1.2
Pretax Income	616.8	600.2	715.7	700.6	769	418.7
Income Tax Expense	125.1	107.5	122.3	114.7	107.2	72.5
Net Income	491.7	492.7	593.4	585.9	661.8	346.2
Net Income to Common	491.7	492.7	593.4	585.9	661.8	346.2
Net Income Growth	-1.58%	-16.97%	1.28%	-11.47%	91.16%	43.23%
Shares Outstanding (Basic)	72	73	74	74	74	74
Shares Outstanding (Diluted)	73	74	75	76	76	76
Shares Change (YoY)	-1.55%	-2.13%	-0.66%	-0.66%	0.66%	0.53%
EPS (Basic)	6.79	6.75	7.99	7.88	8.90	4.68
EPS (Diluted)	6.75	6.69	7.88	7.73	8.67	4.57
EPS Growth	0.17%	-15.10%	1.94%	-10.84%	89.72%	42.37%
Free Cash Flow	379.1	276.4	414.5	439.4	330.6	298.1
Free Cash Flow Per Share	5.20	3.75	5.50	5.80	4.33	3.93
Dividend Per Share	0.840	0.810	0.770	0.730	0.690	0.650
Dividend Growth	5.00%	5.20%	5.48%	5.80%	6.15%	6.56%
Gross Margin	35.58%	34.51%	38.31%	39.36%	41.59%	35.76%
Operating Margin	21.08%	20.52%	23.94%	26.46%	27.14%	19.68%
Profit Margin	16.29%	17.03%	20.12%	20.29%	23.37%	16.13%
Free Cash Flow Margin	12.56%	9.55%	14.05%	15.22%	11.68%	13.88%
EBITDA	801.4	749	843.5	884.4	890.9	531.7
EBITDA Margin	26.55%	25.89%	28.59%	30.64%	31.46%	24.77%
D&A For EBITDA	165.1	155.4	137.3	120.6	122.3	109.1
EBIT	636.3	593.6	706.2	763.8	768.6	422.6
EBIT Margin	21.08%	20.52%	23.94%	26.46%	27.14%	19.68%
Effective Tax Rate	20.28%	17.91%	17.09%	16.37%	13.94%	17.32%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q